sertraline has been researched along with Candidiasis, Vulvovaginal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dierich, MP; Fuchs, D; Lass-Flörl, C; Ledochowski, M; Semenitz, E | 1 |
1 other study(ies) available for sertraline and Candidiasis, Vulvovaginal
Article | Year |
---|---|
Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |